济川药业股价下跌2.54% 曹飞完成要约收购持股比例达56.07%

Core Points - As of July 31, 2025, Jichuan Pharmaceutical's stock price closed at 26.85 yuan, down 0.70 yuan or 2.54% from the previous trading day [1] - The company reported a trading volume of 101,562 hands and a transaction amount of 275 million yuan on the same day [1] Company Overview - Jichuan Pharmaceutical is primarily engaged in the research, development, production, and sales of pharmaceuticals, covering both traditional Chinese medicine and chemical drugs [1] - The company's business segments include traditional Chinese medicine, Hubei region, and influenza [1] Shareholding Changes - On July 31, Jichuan Pharmaceutical announced that the share acquisition by Cao Fei has been completed [1] - Following the completion of the acquisition, Cao Fei directly and indirectly controls a total of 517 million shares, accounting for 56.07% of the company's total share capital [1] - Cao Fei and his concerted party, Cao Longxiang, jointly control 564 million shares, representing 61.15% of the total share capital [1] Market Activity - On the same day, the net outflow of main funds was 10.0462 million yuan, accounting for 0.04% of the circulating market value [1]